Shanghai ZJ Bio-Tech Co., Ltd

688317

CNE100005DB6

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
16.1 ^CNY	-1.53%		-1.35%	-23.26%

Apr. 28	Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 03	Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	CI

Shanghai ZJ Bio-Tech Co., Ltd. authorizes a Buyback Plan.

February 17, 2024

The Board of Directors of Shanghai ZJ Bio-Tech Co., Ltd. has authorized a buyback plan on February 18, 2024.

Latest news about Shanghai ZJ Bio-Tech Co., Ltd

Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 28	CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	Apr. 02	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Shanghai ZJ Bio-Tech Co., Ltd. announces an Equity Buyback for CNY 70 million worth of its shares.	Feb. 18	CI
Shanghai ZJ Bio-Tech Co., Ltd. authorizes a Buyback Plan.	Feb. 17	CI
Certain A Shares of Shanghai ZJ Bio-Tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 19-JAN-2024.	Jan. 18	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shanghai ZJ Bio-Tech Chairman to Buy 15 Million Yuan More Shares	22-12-01	MT
Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback announced on May 6, 2022 has expired.	22-11-03	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.	22-10-10	CI
Shanghai ZJ Bio-Tech Co., Ltd.(XSSC:688317) added to S&P Global BMI Index	22-09-19	CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.	22-07-04	CI
CJ Cheiljedang Corporation completed the acquisition of 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd..	21-10-28	CI
CJ Cheiljedang Corporation signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. for KRW 25 billion.	21-07-20	CI

Chart Shanghai ZJ Bio-Tech Co., Ltd

Duration

Period

More charts

Shanghai ZJ Bio-Tech Co Ltd is a China-based company that mainly engaged in the production of molecular diagnostic reagents. The Company is mainly engaged in the research, development, production and sales of genetic diagnostic reagents and equipment. The Company's main products include nucleic acid detection kits and molecular diagnostic instruments. The Company's products are mainly used in areas such as emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company mainly conducts business within the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
SHANGHAI ZJ BIO-TECH CO., LTD	-23.26%	428M
BIOMÉRIEUX	-7.26%	12.1B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.93%	8.16B
DIASORIN S.P.A.	+4.57%	5.78B
LANTHEUS HOLDINGS, INC.	+30.16%	5.59B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.47%	4.23B
10X GENOMICS, INC.	-57.20%	2.87B
ANDON HEALTH CO., LTD.	+12.56%	2.71B
VITROLIFE AB	-6.68%	2.35B
MYRIAD GENETICS, INC.	+27.38%	2.21B

Diagnostic & Testing Substances